Related Experiment Video
Updated: Aug 7, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis
Rita Del Pinto1,2,3, Corrado Giua4, Enrico Keber4
1Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, 67100, L'Aquila, Italy. rita.delpinto@univaq.it.
Insights
New European guidelines significantly increase cardiovascular disease risk assessment for hypertensive adults over 50. Effective risk factor management is crucial for preventing fatal and non-fatal cardiovascular events.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Cardiovascular diseases (CVD) represent a major global health challenge.
- Effective CVD prevention necessitates managing modifiable and unmodifiable risk factors.
Purpose of the Study:
- To evaluate cardiovascular risk and hypertension control rates in hypertensive adults aged ≥50 years using the 2021 European Society of Cardiology (ESC) guidelines.
- To compare risk stratification and control rates with previous guidelines.
Main Methods:
- Secondary analysis of data from the Save Your Heart study.
- Inclusion of treated hypertensive adults aged ≥50 years.
- Application of 2021 ESC guidelines for CVD risk assessment and hypertension control.
Main Results:
- The proportion of individuals classified as high or very high cardiovascular risk increased from 48.7% to 77.1% with the new guidelines.
- A trend towards lower hypertension control rates was observed under the 2021 guidelines compared to the 2018 edition.
Conclusions:
- The 2021 European Guidelines identify a hypertensive population at very high risk of cardiovascular events.
- Improved risk factor management is essential for patients and stakeholders to mitigate cardiovascular risk.
Introduction:
Cardiovascular diseases (CVD) are a leading cause of death worldwide, and several modifiable and unmodifiable risk factors contribute to this burden of disability and mortality. Thus, effective cardiovascular prevention relies on appropriate strategies to control risk factors within the frame of unmodifiable traits.
Methods:
We conducted a secondary analysis of treated hypertensive adults aged ≥ 50 years enrolled in Save Your Heart. CVD risk and hypertension control rates based on the 2021 updated European Society of Cardiology guidelines were evaluated. Comparisons with previous standards in terms of risk stratification and hypertension control rates were performed.
Results:
Among the 512 patients evaluated, with the application of the new parameters for fatal and non-fatal cardiovascular risk assessment, the proportion of individuals at high or very high risk rises from 48.7 to 77.1% of cases. A trend towards lower hypertension control rates was observed based on 2021 European guidelines compared with the 2018 edition (likelihood estimate for difference: 1.76%, 95% CI - 4.1 to 7.6%, p = 0.589).
Conclusions:
In this secondary analysis on the Save Your Heart study, the application of the new parameters reported in the European Guidelines for Cardiovascular Prevention 2021 showed a hypertensive population with a very high probability of encountering a fatal or non-fatal cardiovascular event due to failure to control risk factors. For this reason, a better management of risk factors must be the main goal for the patient and all the involved stakeholders.
More Related Videos
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Factors affecting Blood pressure
Physiological Factors:
Hypertension I: Introduction

